TrialJournal of viral hepatitis2014

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.

P Colombatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.